Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
The efficacy of a novel triazole, SCH51048, was assessed with a murine model of pulmonary aspergillosis and was compared with those of SCH39304 and itraconazole. A wide range of doses of SCH51048 (5 to 50 mg/kg of body weight) was evaluated. Mortality was significantly delayed in mice treated with d...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1995
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7574528/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.6.1345 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|